Adverse Effects of Breast Cancer Chemotherapy

Undergoing chemotherapy for breast cancer patients will undoubtedly increase overall survival; the occurrence of adverse events is inevitable. Of all the side effects of chemotherapy, bone marrow toxicity. The bone marrow primarily functions as the production website of white and red blood cells. Most women treated with chemotherapy for breast cancer will experience a decline in their white blood cell count, most usually seven to fourteen days after treatment. This drop of cell count is known as leucopenia. Thus, although on chemotherapy, the breast cancer patient should be alert for any infection, which is the 1st sign of bone marrow suppression. The most immediate symptom of an infection will be a fever.

As a cancer patient, it is critical that you alert your physician at the initial signs of infection and to receive antibiotic therapy. There are some clinical protocols that routinely put women on antibiotics the second week after every chemotherapy session as a prophylactic measure against infection. Gene technology is now trying to get into the picture of safer chemotherapy. There are genetically engineered bone marrow stimulants readily available for women who develop severe depression of their white or red blood cell counts. Drugs like Neuprogen and Epogen are some of these agents. Fortunately, the toxicity to the bone marrow that occurs after chemotherapy is temporary and reversible. If an infection occurs, it is potentially extremely serious and must be addressed immediately to avoid fatal complications.

Also showing sensitivity to anticancer drugs are the cells that line the gastrointestinal tract from the mouth to the anus, which undergo cell division regularly and which the body manufactures and replaces each and every few days. Some anticancer drugs interrupt this production of cells, causing little ulcers. Fortunately, this is fairly unusual in breast cancer chemotherapy, but can still happen. The mouth and the rectal areas are the most susceptible.

The most typical gastrointestinal symptom of cancer chemotherapy is nausea and vomiting, most frequently during the week instantly following treatment. This is primarily due to a massive mediator release of substances called histamines, which are stored in the cells lining the gastrointestinal tract. New drugs can now stop the release of histamines for patients undergoing chemotherapy. Since the discover and appropriate use of supportive medications, the nausea and vomiting accompanying chemotherapy is significantly less of a problem than it utilized to be. The incidence of these adverse events varies depending on the drugs utilized and the dose intensity with which they are employed.

For most women, hair loss (alopecia) is a really distressing side effect of a few anticancer agents. Some of the agents such as doxorubicin, paclitaxel, docetaxel can cause uniform temporary alopecia, especially from the scalp. Other drugs only cause minimal hair thinning. Many of the breast cancer chemotherapy regimens have doxorubicin and some of the newer ones have paclitaxel or docetaxel, so temporary hair loss ought to be anticipated after undergoing chemotherapy.

Mainly because side effects can be debilitating, many women want to know if they can continue to work although on chemotherapy. The answer varies depending on the regimen utilized and the stress and demands of the specific job. Regardless of whether the patient decides to continue working or not, it is important that during the many months of chemotherapy, she need to plan to take it easy - decrease as significantly stress as she can. She should engage herself with loved ones, friends and extend support system particularly during the periods when she is down and not feeling well. For more info about "Symptom Of Breast Cancer", you need to go to: Symptom Of Breast Cancer Adverse Effects of Breast Cancer Chemotherapy